“Tocilizumab: Una revisión de su efectividad y seguridad para el tratamiento de COVID-19: Effectiveness and Safety of Tocilizumab for the Treatment of COVID-19”, Rev. Inv. Inf. Sal., vol. 17, no. 43, pp. 122–129, Dec. 2022, doi: 10.52428/20756208.v17i43.401.